Community Perspectives on iPrEP Research: An Interactive Discussion of Issues & Opinions
December 9, 2009This teleconference is a continuation of the intermittent pre-exposure prophylaxis (iPrEP) conversation being organized by the Research Working Group of the PrEP Committee. It was designed to provide a forum for community members to express their thoughts and opinions on iPrEP research. To learn more, about iPrEP and where to get background information, read our Advocates' Network announcement on this teleconference.
Listen to the Community Perspectives on iPrEP Research: An Interactive Discussion of Issues & Opinions
Agenda
PrEP Updates: DSMB Reviews & Report-Back from amfAR/AVAC iPrEP Workshop
Mitchell Warren, Executive Director, AVAC
Key Questions About iPrEP Research: What Is Your Perspective?
Jeff McConnell, Co-Investigator, Grant Laboratory, Epidemiology and Clinical Studies, Gladstone Institute of Virology and Immunology, University of California San Francisco (UCSF)
See the i-PrEP Discussion Questions that Jeff has drafted for consideration before the call.
Advocacy Issues in iPrEP Research: Is Current Research and Planning Adequate?
Chris Collins, Vice President and Director, Public Policy, amfAR, The Foundation for AIDS Research